IRIS UniCatt

Barone, Carlo Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.132
NA - Nord America 2.436
AS - Asia 1.005
SA - Sud America 163
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 6.779
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.407
DE - Germania 1.449
CN - Cina 429
SE - Svezia 425
SG - Singapore 278
IT - Italia 251
PL - Polonia 227
UA - Ucraina 179
BR - Brasile 151
GB - Regno Unito 133
FR - Francia 118
IE - Irlanda 100
IN - India 78
FI - Finlandia 64
RU - Federazione Russa 64
ID - Indonesia 62
TR - Turchia 36
BE - Belgio 33
VN - Vietnam 26
CI - Costa d'Avorio 21
IR - Iran 20
NL - Olanda 18
CA - Canada 15
HK - Hong Kong 14
JP - Giappone 12
KR - Corea 12
LT - Lituania 12
RO - Romania 11
MX - Messico 10
AT - Austria 8
ES - Italia 8
IQ - Iraq 6
AU - Australia 5
CZ - Repubblica Ceca 5
PK - Pakistan 5
RS - Serbia 5
AR - Argentina 4
CH - Svizzera 4
EC - Ecuador 4
MA - Marocco 4
PT - Portogallo 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
MD - Moldavia 3
PE - Perù 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
BG - Bulgaria 2
GE - Georgia 2
JO - Giordania 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NO - Norvegia 2
PS - Palestinian Territory 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
IL - Israele 1
KE - Kenya 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 6.779
Salva come PNG Salva come JPEG
Città #
Chandler 476
Warsaw 207
Singapore 175
Ashburn 158
Ann Arbor 123
Jacksonville 114
Dublin 98
San Mateo 97
Nürnberg 89
Nanjing 85
Wilmington 84
Cattolica 82
Jakarta 60
New York 56
Boston 54
Dearborn 54
Fairfield 42
Houston 40
Moscow 40
Woodbridge 40
Chicago 36
Los Angeles 36
Nanchang 36
Lawrence 34
Brussels 33
Hangzhou 33
Redmond 33
Beijing 31
Munich 31
Redwood City 31
Izmir 27
Marseille 27
Milan 27
Seattle 26
Frankfurt am Main 25
Princeton 25
Rome 24
Shanghai 24
Abidjan 21
Boardman 21
Falls Church 20
Mountain View 20
Helsinki 18
Cambridge 17
Hebei 17
Shenyang 15
Bremen 14
Guangzhou 14
Hyderabad 14
Leawood 14
San Francisco 14
São Paulo 14
Can Tho 13
Changsha 13
Hong Kong 13
Kraków 13
London 13
Norwalk 13
Fremont 11
Kunming 11
Santa Clara 11
The Dalles 11
Augusta 10
Lancaster 10
University Park 10
Detroit 9
Hefei 9
Jiaxing 8
Simi Valley 8
Zhengzhou 8
Andover 7
Jinan 7
Kish 7
Nuremberg 7
Seoul 7
Tianjin 7
Belo Horizonte 6
Brooklyn 6
Changchun 6
Costa Mesa 6
Düsseldorf 6
Mannheim 6
Tokyo 6
Belgrade 5
Lanzhou 5
Mexico City 5
Ottawa 5
Rio de Janeiro 5
San Diego 5
Wroclaw 5
Amsterdam 4
Berlin 4
Cuauhtémoc 4
Goyang-si 4
Miami 4
Mumbai 4
Phoenix 4
Stockholm 4
Tashkent 4
Toronto 4
Totale 3.299
Salva come PNG Salva come JPEG
Nome #
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival 355
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy 317
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 263
KRAS Early Testing: Consensus Iniziative and Cost-Effectiveness Evaluation for metastatic colerectal patiens in an Italian Setting 225
A phase II study of sunitinib in advanced hepatocellular carcinoma 217
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 216
Diagnosis and management of breast lymphoma: A single-institution retrospective analysis 195
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 190
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 169
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 163
Treatment options of simple bone cysts: the role of bone substitutes, growth factors and literature review 144
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 141
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 139
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 139
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 139
Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer 131
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 119
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 118
AMAROS Study: Overall Survival in Breast Cancer Subtypes 118
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report 117
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 116
Are TKIs favourable for the elderly with non-small-cell lung cancer? 114
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 111
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 110
Use of trastuzumab in HER2-positive metastatic breast cancer beyond disease progression: a systematic review of published studies 109
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial 103
The immune response to tumors as a tool toward immunotherapy 101
Advanced colon cancer: staging and prognosis by CEA test 97
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 95
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): A randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX 92
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 92
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 91
Paradox CA 15-3 increase in metastatic breast cancer patients treated with everolimus: A change of paradigm in a case series 88
Gas in portal circulation and pneumatosis cystoides intestinalis during chemotherapy for advanced rectal cancer 85
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 85
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 84
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 83
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 83
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 82
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 79
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies 79
Indications for prophylactic osteosynthesis associated with curettage in benign and low-grade malignant primitive bone tumors of the distal femur in adult patients: a case series 77
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 76
LUX-Lung 7: is there enough data for a final conclusion? 75
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 74
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 70
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 69
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 69
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 65
Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score 63
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 59
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 58
Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II study 56
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis 54
Randomised, placebo-controlled, double-blind, parallele-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer 53
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 51
Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations 46
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 45
Multidisciplinary approach for HCC patients: hepatology for the oncologists 43
New life for retrospective study in the precision oncology era 42
Targeted therapy in advanced gastric carcinoma: The future is beginning 32
Soft tissue metastases in lung cancer: a review of the literature 31
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial 25
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 24
Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy 11
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 7
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report 4
Totale 6.873
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.471
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202072 0 0 0 0 0 0 0 0 0 0 0 72
2020/2021581 27 76 46 40 86 33 69 14 76 28 69 17
2021/2022704 54 44 19 79 49 29 16 108 37 49 80 140
2022/20231.267 182 179 106 226 54 158 64 103 118 25 41 11
2023/2024542 24 162 21 18 15 82 33 42 5 15 51 74
2024/20251.002 25 52 90 53 95 44 47 50 128 111 188 119
Totale 6.873